Skip to content
DraconiticResearch
Search Sources API
201,642 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BY-NC-ND 4.0The Saudi Dental Journal

Development and internal validation of a prognostic model for predicting periodontitis progression using clinical and behavioural factors

  • Ankita Mathur1
  • Kabir Suman Dash2
  • Santosh Patil3
  • Vini Mehta1,4
4 affiliations
  1. 1Dental Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, India
  2. 2Department of Public Health Dentistry, Kalinga Institute of Dental Sciences (KIDS), Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, India
  3. 3Department of Oral Medicine and Radiology, Chhattisgarh Dental College and Research Institute, Rajnandgaon, India
  4. 4Faculty of Dentistry, University of Ibn al-Nafis for Medical Sciences, Sana’a, 14034 Yemen
Read full textPDFDOICite

Abstract

To develop and internally validate the PERI-Score, a pragmatic prognostic index for estimating 36-month periodontitis progression from routinely available clinical, systemic, and behavioural information. In this prospective single-centre cohort study, 350 consecutive adults with periodontitis received non-surgical periodontal therapy and were followed for 36 months during supportive periodontal therapy (SPT). Progression was operationally defined as clinical attachment loss, represented by an increase (worsening) in clinical attachment level (CAL) of ≥ 2 mm at ≥ 20% of assessable matched sites. The PERI-Score was developed using Cox proportional hazards modelling. Performance was evaluated using a stratified 70:30 development/internal-validation split and 1,000 bootstrap resamples; both subsets originated from the same cohort and therefore represent internal validation. A total of 118 progression events were observed (33.7%). The strongest predictors were Stage III/IV periodontitis (HR 2.64), active smoking (≥ 10 cigarettes/day; HR 2.31), PPD ≥ 5 mm at ≥ 4 sites (HR 2.18), SPT non-compliance (< 75% attendance; HR 2.08), and Grade C periodontitis (HR 1.92), with additional contributions from HbA1c ≥ 7.0%, CAL ≥ 5 mm at ≥ 4 sites, BOP ≥ 30%, Class II/III furcation involvement, FMPS ≥ 30%, and age ≥ 50 years. The internal-validation AUC was 0.843 (95% CI 0.786-0.900), and observed progression increased across the three PERI-Score strata. The PERI-Score is an internally validated candidate prognostic model for 36-month progression during treated periodontal care. It combines baseline disease severity and susceptibility with modifiable systemic and behavioural factors and a longitudinal marker of SPT adherence. It may support risk communication and structured monitoring, but independent multicentre external validation is required before its thresholds are used to determine treatment or recall protocols.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s44445-026-00260-x.

Related

  1. Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation.
    Galip Can Uyar, Kadriye Başkurt, Orhun Akdoğan +8
    The oncologistPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Development and validation of a postoperative prognostic nomogram for early-stage pancreatic cancer
    Pengcheng Cai, Chao Luo, Liangsong Zhao +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  3. Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Development and external validation of an XGBoost-based prognostic model for small cell lung cancer with brain metastases
    Pei Jiao, Chen Chen, Koudong Zhang +2
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. A prognostic model to predict the risk of cesarean delivery after induction of labour: development, validation, and clinical utility
    Eskedar Getie Mekonnen, Samuel Coenen
    Scientific ReportsPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsDOAJ

Cite

BibTeXRIS
BibTeX
@article{mathur2026development,
  title = {{Development and internal validation of a prognostic model for predicting periodontitis progression using clinical and behavioural factors}},
  author = {Ankita Mathur and Kabir Suman Dash and Santosh Patil and Vini Mehta},
  journal = {The Saudi Dental Journal},
  year = {2026},
  month = oct,
  doi = {10.1007/s44445-026-00260-x},
  url = {https://doi.org/10.1007/s44445-026-00260-x},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Development and internal validation of a prognostic model for predicting periodontitis progression using clinical and behavioural factors
AU  - Ankita Mathur
AU  - Kabir Suman Dash
AU  - Santosh Patil
AU  - Vini Mehta
PY  - 2026
DA  - 2026/10/01
JO  - The Saudi Dental Journal
DO  - 10.1007/s44445-026-00260-x
UR  - https://doi.org/10.1007/s44445-026-00260-x
AB  - To develop and internally validate the PERI-Score, a pragmatic prognostic index for estimating 36-month periodontitis progression from routinely available clinical, systemic, and behavioural information. In this prospective single-centre cohort study, 350 consecutive adults with periodontitis received non-surgical periodontal therapy and were followed for 36 months during supportive periodontal therapy (SPT). Progression was operationally defined as clinical attachment loss, represented by an increase (worsening) in clinical attachment level (CAL) of ≥ 2 mm at ≥ 20% of assessable matched sites. The PERI-Score was developed using Cox proportional hazards modelling. Performance was evaluated using a stratified 70:30 development/internal-validation split and 1,000 bootstrap resamples; both subsets originated from the same cohort and therefore represent internal validation. A total of 118 progression events were observed (33.7%). The strongest predictors were Stage III/IV periodontitis (HR 2.64), active smoking (≥ 10 cigarettes/day; HR 2.31), PPD ≥ 5 mm at ≥ 4 sites (HR 2.18), SPT non-compliance (< 75% attendance; HR 2.08), and Grade C periodontitis (HR 1.92), with additional contributions from HbA1c ≥ 7.0%, CAL ≥ 5 mm at ≥ 4 sites, BOP ≥ 30%, Class II/III furcation involvement, FMPS ≥ 30%, and age ≥ 50 years. The internal-validation AUC was 0.843 (95% CI 0.786-0.900), and observed progression increased across the three PERI-Score strata. The PERI-Score is an internally validated candidate prognostic model for 36-month progression during treated periodontal care. It combines baseline disease severity and susceptibility with modifiable systemic and behavioural factors and a longitudinal marker of SPT adherence. It may support risk communication and structured monitoring, but independent multicentre external validation is required before its thresholds are used to determine treatment or recall protocols.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s44445-026-00260-x.
SN  - 1013-9052
SN  - 1658-3558
SN  - 2524-1702
ER  -